The GROWTH consortium, funded by the European Commission (2019-2023), is made up to train a new generation of researchers working on new pathological insights, biomarker diagnostics and personalized nutritional interventions for intestinal failure in neonates and preterm infants.
Academic and industry partners, covering various disciplines ranging from fundamental research to clinical paediatrics and analytical chemistry to organoid and gut-on-chip applications, have teamed up in the European Union.
GROWTH aims to set-up a new European platform that trains young scientists in the industry-led exploration of innovative routes to fully exploit the potential of early life nutrition to prevent inflammatory disease. GROWTH coordinates 8 individual research projects.
If you have any questions you can fill in the form or mail us directly: email@example.com.
The VUMC group of Dr. Tim de Meij discovered strong preclinical microbial alterations underline that gut microbiota is involved in the pathogenesis of late onset sepsis and has large potential as non-invasive biomarkers for early diagnostic purposes. A paper on their longitudinal multicenter case-control study was recently published in Clinical Infectious Diseases.
A successful midterm check meeting of the GROWTH programme!
This symposium offers a unique platform for researchers active in this area of biotechnology, from academia and industry alike, to present recent work, to obtain information on new developments and to exchange views with colleagues from all over the world on scientific progress and applications.
As of December 2020 an Expert Lecture Series with "Omics technologies / Bio-informatics analyses) as main training theme is being organized with specialist lecture every other Friday.
On 15-16 April 2021, the 8th edition of Innovation for Health conference with Health Holland as main partner, takes place as an online edition.